egfr Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions
Excerpt
The systemic treatment options and algorithm for stage iv non-small-cell lung cancer have changed tremendously since 2005, leading to improved survival and quality of life for this group of patients [...]
Share and Cite
Melosky, B. egfr Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions. Curr. Oncol. 2012, 19, 8. https://doi.org/10.3747/co.19.955
Melosky B. egfr Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions. Current Oncology. 2012; 19(1):8. https://doi.org/10.3747/co.19.955
Chicago/Turabian StyleMelosky, B. 2012. "egfr Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions" Current Oncology 19, no. 1: 8. https://doi.org/10.3747/co.19.955
APA StyleMelosky, B. (2012). egfr Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions. Current Oncology, 19(1), 8. https://doi.org/10.3747/co.19.955
